Clinical Trial Update: BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test [Phase 1]

View source ↗

Summary

A Phase 1 study from Bayer comparing BAY1003803 formulations in an open psoriasis plaque test has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BAY1003803

Snippet

Sponsor: Bayer | Conditions: Psoriasis | Phase 1 | Status: COMPLETED